Odysse V2, V2+ Electric Scooters Launched In India, Prices Start At 75,000

Mumbai-based EV maker, Odysse announced the launch of V2 and V2+ electric scooters in India at Rs. 75,000 and Rs. 97,500 (ex-showroom) respectively. With the Odysse V2 and V2+ electric scooters, the company's portfolio now consists of 6 electric models, with two more models to be introduced later this year. Additionally, the company aims to expand its dealer network to 100+ in the coming months. The company said that it plans to expand its production capacity further after the launch of these new vehicles, and set up facilities at new locations apart from Ahmedabad, Mumbai, and Hyderabad.

The Odysse V2 electric scooter ensures a driving range of 150 km.

Also Read: Odysse Launches New Low-Speed Electric Scooter E2Go In India

Nemin Vora, CEO of Odysse said, “It gives us great pride to be launching Odysse's V2 & V2+. India is transitioning towards clean mobility and with Odysse we want to bring about a change in how people commute. The newly launched Scooter is a step forward to strengthen our product portfolio, where electric scooters are consistently witnessing encouragingly high demand. Odysse V2+ with its 150 Km mileage will resolve customers from Range anxiety along with providing them refreshing color and amazing features.”

The Odysse V2 electric scooter gets features like an anti-theft lock, passive battery cooling, ample boot space, a 12-inch front tyre, LED lights, and much more.

Also Read: Mumbai-Based Odysse Electric Vehicles Introduces New Range Of Electric Scooters & Bikes

The Odysse V2 and V2+ electric scooters are equipped with water-resistant IP 67 rated battery options, which ensures a driving range of 150 km. Along with access to a wide range of color selections, consumers will also get features like an anti-theft lock, passive battery cooling, ample boot space, a 12-inch front tyre, LED lights, and much more. Apart from the two new vehicles, the Odysse stables already offer four electric two-wheelers- E2go, Hawk+, Racer, and Evoqis.